Clinical practices of the management of nonvalvular atrial fibrillation and outcome of treatment: A representative prospective survey in tertiary healthcare centers across Turkey

Ozin B., AYTEMİR K., Aslan O., Ozcan T., KANADAŞI M., DEMİR M., ...Daha Fazla

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.46, sa.2, ss.92-102, 2018 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5543/tkda.2017.79367
  • Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.92-102
  • Anahtar Kelimeler: Anticoagulants, atrial fibrillation, quality of life in atrial fibrillation, treatment outcome in atrial fibrillation, warfarin, STROKE PREVENTION, ANTITHROMBOTIC THERAPY, RISK-FACTORS, ANTICOAGULATION, WARFARIN, ASPIRIN, CLOPIDOGREL, SCORES, TRIAL
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: The goal of this study was to define clinical practice patterns for assessing stroke and bleeding risks and thromboprophylaxis in nonvalvular atrial fibrillation (NVAF) and to evaluate treatment outcomes and patient quality of life.